Fact CheckerSign in

NCT07120997Recruiting

Prunes Preventing Bone Loss in Perimenopause

A Prevention Strategy for the Indication of Prune Consumption in Perimenopausal Females: Can Prunes Attenuate Bone Loss?

Source: ClinicalTrials.gov · Last updated 4 Feb 2026

Brief summary (registry, in English)

Dietary interventions of prune consumption during the transmenopausal period are innovative methods to prevent bone loss. Modern medicine does not intervene to prevent or attenuate this highly vulnerable period of bone loss which, if successfully attenuated, can potentially prevent/delay osteoporosis in women. The transmenopausal period represents an opportunistic window for the study because bone loss is at its greatest at this time, with females losing as much as 6-7% of bone. If this project is successful at attenuating bone loss, it can immediately be disseminated to the public to promote prune consumption to slow down and attenuate perimenopausal bone loss. As such, this project could improve the long-term bone health of females and avoid or delay osteoporosis and improve quality of life. The long-term goal of this study is to test the novel hypothesis that prune consumption for 18 months during the 3-year transmenopausal period prevents the dramatic rate of bone loss in perimenopausal females during a window of heightened physiological vulnerability. At Penn State University, the study will compare the effects of 18 months of daily dietary consumption of 50 g of prunes (5-6) versus a no-prune control group on bone outcomes (bone mineral density, bone geometry), mechanistic factors (bone and inflammatory markers, inflammatory response of ex vivo cultured peripheral blood mononuclear cells, monocytes), and gut microbiome.

Status (registry)
Recruiting
Study type
Interventional
Enrollment
124 (estimated)
First submitted
31 Jul 2025
Start date
11 Dec 2025
Primary completion date
Sept 2029
Lead sponsor
Penn State University
Diseases
Osteoporosis
NCT number
NCT07120997

What you commit to

  • Study type: Interventional
  • Planned participants: 124
  • From 11 Dec 2025 to the primary completion date, Sept 2029
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • History of spinal stenosis
  • History of heart attack, stroke, thromboembolism, kidney disease, malabsorption syndrome, or seizure disorders
  • Positive for HIV, Hep-C or Hep-B surface antigen and malignancy

Age

  • History of vertebral fracture or fragility fracture of the wrist, humerus, hip or pelvis after age 45 yr)

Other

  • Subjects who regularly consume prunes, dried apples, prune juice, or heavy consumers of blueberries (1 cup or more/day)
  • Untreated hyper- or hypothyroidism
  • Current hyper- or hypoparathyroidism
  • Significantly impaired renal function
  • Current hypo- or hypercalcemia
  • Use of the following agents affecting bone metabolism: intravenous bisphosphonates at any time; fluoride (for osteoporosis) within the past 24 months; denosumab at any time; bisphosphonates, parathyroid hormone or strontium within the past 12 months; calcitonin; selective estrogen receptor modulators within the past 12 months; systemic oral or transdermal estrogen within the past 3 months; systemic glucocorticosteroids (≥ 5 mg prednisone equivalent per day for more than 10 days); or tibolone within the past 3 months
  • Hormonal contraception within the past three months
  • Subjects who will not consume study provided dietary items or who will not stop taking their own natural product supplements

Who the study is looking for

  • Age 44 to 55 years
  • Not severely obese (BMI \<35 kg/m\^2)
  • Healthy (determined by a screening questionnaire, physical and medical history by a certified nurse practitioner, complete metabolic panel, and complete blood count)
  • Willing to include prunes in their daily diet
  • Not taking any natural dietary supplement containing phenolics, i.e.,\< 1 cup/day of blueberries or apples for at least 2 months prior to study entry
  • Non-smoking
  • Ambulatory
  • No menses for ≥60 days but not more than 18 months post final menstrual period
  • Only participants who have a determinable natural (not surgical) final menstrual period date are eligible

Age in the registry: 44 years to 55 years · Sex: Female · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Women's Health and Exercise Laboratory, The Pennsylvania State University
Coordinator of this site? Confirm its status
University ParkUnited StatesRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.